Suneel Chilukuri, MD: Regenerative Medicine and the Future of Scar Treatment

Dr. Chilukuri explores the evolving role of regenerative medicine in wound healing and scar management, drawing from his presentation at the DERM2026 NP/PA CME Conference. He discusses how the body’s ability to heal with minimal scarring changes with age and reviews emerging strategies designed to influence inflammation and support more favorable healing.

Topics Covered

  • Regenerative medicine approaches to wound healing and scar management
  • The relationship between aging, inflammation, and scar formation
  • Exosomes as an emerging approach to modulating early wound inflammation
  • Polynucleotides and their potential role in improving the appearance of scars
  • Neuromodulators as a strategy for influencing abnormal scarring
  • Emerging applications of botulinum toxin type E

 

Explore Related Resources

MORE DEF 2026 CONFERENCE COVERAGE:

Alexa Hetzel, PA-C: Tips for Publishing a Case Report
Alexa Hetzel, PA-C, outlines the journey of getting a case study published. The process begins with picking an interesting patient case, thoroughly documenting the treatment
David Cotter, MD, PhD: Emerging Technologies for Moles and Melanoma

Dr. Cotter explores emerging technologies that may enhance the evaluation, risk stratification, and monitoring of melanoma and atypical melanocytic lesions. He reviews tools ranging from

Andrea Nguyen, PA-C, MS: Poster Session Highlights
Andrea Nguyen, PA-C, MS, summarized several key poster presentations based on a presentation at DEF Essential Resource Meeting 2026 (DERM2026) NP/PA CME Conference. The first
Andrew Mastro, MS, PA-C: Case Pearls and Clinical Dilemmas in Dermatology
Andrew Mastro, MS, PA-C, recounted his experience on a panel called "What's Behind the Curtain?" where experts answered top audience questions using case-based pearls based
David Cotter, MD, PhD: Empowering Clinical Decision-Making with Upadacitinib Data
Dr. Cotter discusses how clinical trial data can help clinicians overcome therapeutic inertia when considering JAK inhibitors for patients with moderate-to-severe atopic dermatitis. Drawing from
Kara Gooding, PA-C: Decoding Benign Versus Malignant Pink Lesions
Kara Gooding, PA-C, discusses the challenges of distinguishing benign pink lesions from potentially malignant skin cancers, drawing from her presentation at the DERM2026 NP/PA CME
Andrew Blauvelt, MD, MBA: The Importance of 100% Skin Clearance in Psoriasis Management
Dr. Blauvelt discusses the clinical importance of achieving complete skin clearance in patients with psoriasis, drawing from his presentation at the DERM2026 NP/PA CME Conference.
Andrea Nguyen, PA-C, MS: Advancing Hidradenitis Suppurativa Care
Andrea Nguyen, PA-C, MS, provides a detailed recap of her presentation on HS, which addressed the critical need for a multifactorial management approach, highlighting the
Kara Gooding, PA-C: Advancing Your Career Through Negotiation, Advocacy, and Risk-Taking

Kara Gooding, PA-C, discusses the importance of self-advocacy, negotiation, and strategic risk-taking in building a successful medical career, drawing from her presentation at the DERM2026